Regulatory Interactions between Iron and Nitric Oxide Metabolism for Immune Defense against Plasmodium falciparum Infection
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Iron chelation therapy of Plasmodium falciparum infection alleviates the clinical course of cerebral malaria in children. This study assessed the underlying mechanisms of this therapy. Cytokine stimulation of human (intestinal cell line DLD-1) or murine cells (murine macrophage cell line RAW 264.7) resulted in increased nitric oxide (NO) formation and decreased survival of plasmodia within cocultured human erythrocytes. The addition of desferrioxamine (DFO) before cytokine treatment increased both NO formation and parasite killing but had no effect in the presence of the inhibitor of NO formation, L-N6-(1-iminoethyl)-lysine. Moreover, peroxynitrite, which is formed after chemical reaction of NO with superoxide, appears to be the principal effector molecule for macrophage-mediated cytotoxicity toward P. falciparum, and interferon-gamma is a major regulatory cytokine for this process. The effect of DFO on the clearance of plasmodia appears to be due to enhanced generation of NO, rather than to limitation of iron availability to the parasite.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This pathway appears to be partly responsible for the beneficial clinical effects of iron chelators observed in several experimental infection systems (Mencacci et al., 1997; Fritsche et al., 2001; Ibrahim et al., 2007; Bellmann-Weiler et al., 2013; Nairz et al., 2013).”
From Iron at the interface of immunity and infection (2014) · cites this paper as Fritsche et al., 2001
In the citing paper
“the malarial parasite Plasmodium falciparum requires considerable iron for growth, and there is evidence that lowering the amount of available iron provides a promising route to antimalarials (e.g. [1478-1494]”
From Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases (2009) · cites this paper as [1487]
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids
Green, L. C., Wagner, D. A., Glogowski, J., Skipper, P. L., Wishnok, J. S., & Tannenbaum, S. R. (1982) · Analytical Biochemistry · doi:10.1016/0003-2697(82)90118-x · Cited by 12,077 · cited 1×
“The concentration of nitrite in tissue culture supernatants was determined by the Griess reaction [20].”
MethodNITRIC OXIDE AND MACROPHAGE FUNCTION
MacMicking, J., Xie, Q.-W., & Nathan, C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.323 · Cited by 4,211 · cited 3×
“stimulation by cytokines such as TNF-a, IL-1/3 and/or IFN-,yl LPS appears to be a pivotal antiplasmodial effector mechanism [9].”
BackgroundBiochemistry of nitric oxide and its redox-activated forms
Stamler, J. S., Singel, D. J., & Loscalzo, J. (1992) · Science · doi:10.1126/science.1281928 · Cited by 2,744
Secretory products of macrophages.
Nathan, C. F. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112815 · Cited by 2,615 · cited 3×
“, vascular relaxation, neurotransmission, and cellular cytotoxicity) against various microorganisms [9, 10].”
BackgroundRedox signaling: Nitrosylation and related target interactions of nitric oxide
Stamler, J. S. (1994) · Cell · doi:10.1016/0092-8674(94)90269-0 · Cited by 1,723 · cited 1×
“Because NO and 02- together form ONOO [25, 26], this short-lived radical probably is the major effector molecule for antiplasmodial activity of cytokine-stimulated macrophages.”
BackgroundFree radicals and phagocytic cells
Rosen, G. M., Pou, S., Ramos, C. L., Cohen, M. S., & Britigan, B. E. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.2.7540156 · Cited by 478 · cited 1×
“It is well established that, as a major cytotoxic effector mechanism, monocytes/macrophages produce and excrete toxic oxygen compounds, such as hydroxyl radicals, superoxide anion, or hydrogen peroxide, after stimulation with IFN-y [10, 23].”
BackgroundIron regulates nitric oxide synthase activity by controlling nuclear transcription.
Weiss, G., Werner-Felmayer, G., Werner, E. R., Grünewald, K., Wachter, H., & Hentze, M. W. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.3.969 · Cited by 412 · cited 3×
“This was of interest because of in vitro data showing that iron inhibits the formation of NO by a transcriptional mechanism [17], which leads to reduced binding of NF-IL6 to the iNOS promoter [18], and because of in vivo data showing increased serum nitrite and nitrate levels in children receiving DFO in addition to s…”
BackgroundResultSelf-citationBiosynthesis of nitric oxide activates iron regulatory factor in macrophages.
Drapier, J. C., Hirling, H., Wietzerbin, J., Kaldy, P., & Kühn, L. C. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06038.x · Cited by 401 · cited 1×
“NO regulates the expression of critical mRNAs in cellular iron metabolism, namely ferritin and transferrin receptor mRNA at the posttranscriptional levels via activation of iron regulatory proteins [15, 16], and iron inhibits the expression of inducible NO synthase (iNOS), the enzyme responsible for high-output format…”
BackgroundTranslational regulation via iron‐responsive elements by the nitric oxide/NO‐synthase pathway.
Weiss, G., Goossen, B., Doppler, W., Fuchs, D., Pantopoulos, K., Werner‐Felmayer, G., Wachter, H., & Hentze, M. W. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06039.x · Cited by 389
Cited by
Nitric oxide and the immune response
Bogdan, C. (2001) · Nature Immunology · doi:10.1038/ni1001-907 · Cited by 3,447
Melanogenesis and associated cytotoxic reactions: Applications to insect innate immunity
Nappi, A. J., & Christensen, B. M. (2005) · Insect Biochemistry and Molecular Biology · doi:10.1016/j.ibmb.2005.01.014 · Cited by 675
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
“[1320-1336], but cf.”
Mechanisms of nutrient modulation of the immune response
Cunningham-Rundles, S., McNeeley, D. F., & Moon, A. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.04.036 · Cited by 534
Iron, anaemia, and inflammatory bowel diseases
Gasche, C., Lomer, M. C. E., Cavill, I., & Weiss, G. (2004) · Gut · doi:10.1136/gut.2003.035758 · Cited by 494
Self-citation
Metadata
- Authors
- Fritsche, G., Larcher, C., Schennach, H., & Weiss, G.
- Affiliations
- University Hospital Innsbruck (AT)
- Innsbruck Medical University (AT)
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-05
- Volume
- 183
- Issue
- 9
- Pages
- 1388-1394
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2137614946
- Cited by
- 84
- References
- 31
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 3 · 2022: 1 · 2021: 3 · 2020: 2 · 2019: 2 · 2018: 3 · 2017: 2 · 2016: 1 · 2015: 3 · 2014: 2 · 2013: 2 · 2012: 5
- FWCI
- 8.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Keywords
- Plasmodium falciparum, cerebral malaria, iron chelation therapy, deferoxamine, nitric oxide, peroxynitrite, macrophage cytotoxicity, interferon-gamma, cytokine regulation, parasite clearance, immune defense, iron metabolism
- MeSH terms
- Animals, Cells, Cultured, Deferoxamine, Erythrocytes, Humans, Interferon-gamma, Iron, Iron Chelating Agents, Lipopolysaccharides, Macrophages, Nitric Oxide, Plasmodium falciparum, RNA, Messenger, Superoxide Dismutase, Tumor Cells, Cultured, Malaria, Falciparum, Coculture Techniques, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Regulatory Interactions between Iron and Nitric Oxide Metabolism for Immune Defense against Plasmodium falciparum Infection. https://app.cochat.ai/papers/10.1086/319860
- The paper
- Fritsche, G., Larcher, C., Schennach, H., & Weiss, G. (2001). Regulatory Interactions between Iron and Nitric Oxide Metabolism for Immune Defense against Plasmodium falciparum Infection. The Journal of Infectious Diseases. https://doi.org/10.1086/319860
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.